Xeljanz Special Investigation for Long-term Use in UC Patients

XELJANZ(REGISTERED) TABLETS 5 MG SPECIAL INVESTIGATION(INVESTIGATION OF LONG-TERM USE IN PATIENTS WITH ULCERATIVE COLITIS)

Secondary data collection study: safety and effectiveness of Xeljanz in UC patients under Japanese medical practice

This investigation aims to examine the safety and effectiveness of Xeljanz in post-marketing clinical settings when it is administered chronically to patients with ulcerative colitis, based on the approval conditions.

Inclusion Criteria:

• Patients with ulcerative colitis treated with XELJANZ
• Patients naive to XELJANZ in the treatment of ulcerative colitis

Exclusion Criteria:

- None